You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

matched and mismatched unrelated donors

Showing 1 - 25 of 5,104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,

Completed
Has Results
  • Acute Myeloid Leukemia
  • Advanced Myelodysplastic Syndromes
  • Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 27, 2021

Non-Malignant Hematologic Disorders Trial in New York (Melphalan, Thiotepa, Clofarabine)

Terminated
Has Results
  • Non-Malignant Hematologic Disorders
  • New York, New York
    Memorial SloanKettering Cancer Center
Mar 1, 2021

Myeloid Malignancies Trial in Italy (GvHD prophylaxis)

Recruiting
  • Myeloid Malignancies
  • GvHD prophylaxis
  • Alessandria, Italy
  • +32 more
Nov 23, 2022

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

Completed
  • Severe Aplastic Anemia
  • Bone Marrow Failure Syndromes
  • Bone marrow transplant
  • +7 more
  • Baltimore, Maryland
  • +1 more
Feb 10, 2022

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022

Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 4, 2022

Acute Myeloid Leukemia Trial in Seoul (Transplants from 8/8-matched Unrelated donors, Transplants from

Unknown status
  • Acute Myeloid Leukemia
  • Transplants from 8/8-matched Unrelated donors
  • Transplants from family-mismatched/haploidentical donors
  • Seoul, Korea, Republic of
    Catholic Blood and Marrow Transplantation Center, Seoul St. Mary
Sep 17, 2019

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Blood Stem Cell Transplant Failure, Leukemia, Hematologic Malignancies Trial in Houston (Cyclophosphamide, Fludarabine,

Completed
Has Results
  • Blood Stem Cell Transplant Failure
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 12, 2020

Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

Not yet recruiting
  • Graft Vs Host Disease
  • +5 more
  • CliniMACS® device
  • (no location specified)
Jul 20, 2023

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Atorvastatin, Methotrexate,

Withdrawn
  • Acute Myeloid Leukemia
  • +2 more
  • Maywood, Illinois
    Loyola University Medical Center
Apr 23, 2021

Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

Recruiting
  • Sickle Cell Anemia
  • +2 more
  • CD3/CD19 depleted leukocytes
  • +6 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
May 4, 2022

Hematologic Diseases Trial in Palo Alto (biological, device, drug)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Mar 25, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
Apr 4, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, MDS Trial in United States (CliniMacs TCR alpha-beta-Biotin system)

Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CliniMacs TCR alpha-beta-Biotin system
  • Los Angeles, California
  • +9 more
Feb 10, 2022

Immunodeficiencies Trial in Philadelphia (CliniMACs)

Active, not recruiting
  • Immunodeficiencies
  • CliniMACs
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 1, 2022

Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee

Completed
  • Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
  • Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
  • CliniMACS (CD+3, CD+19 depletion)
  • +2 more
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Oct 21, 2021

End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,

Not yet recruiting
  • End Stage Kidney Disease
  • +3 more
  • Donor CD34+, CD3+. and belumosudil
  • Los Angeles, California
    University of California, Los Angeles
Apr 6, 2023

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)

Recruiting
  • Graft-versus-host Disease
  • New York, New York
    NYU Langone Health
Mar 24, 2022

DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

Recruiting
  • DOCK8 Deficiency
  • Reduced-intensity hematopoietic stem cell
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation

Completed
  • Stem Cell Transplantation
    • Princeton, New Jersey
      Local Institution
    Jun 13, 2022